NDC 67457-583 – Fondaparinux Sodium
Fondaparinux Sodium 5 mg/.4mL · Injection, Solution · Subcutaneous
Product NDC67457-583
Product details
- Brand name
- Fondaparinux Sodium
- Generic name
- Fondaparinux sodium
- Labeler
- Mylan Institutional LLC
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- NDA AUTHORIZED GENERIC · NDA021345
- Marketed since
- January 5, 2015
- Listing expires
- December 31, 2027
- Pharmacologic class
- Factor Xa Inhibitor
Active ingredients
- Fondaparinux Sodium 5 mg/.4mL
Uses, dosage, side effects and warnings for Fondaparinux Sodium →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 67457-583-04 | 10 SYRINGE, GLASS in 1 CARTON (67457-583-04) / .4 mL in 1 SYRINGE, GLASS (67457-583-00) | Jan 5, 2015 |
Other Fondaparinux Sodium products
- 55150-230 Fondaparinux Sodium 2.5 mg/.5mL · Injection, Solution · Eugia US LLC
- 55150-231 Fondaparinux Sodium 5 mg/.4mL · Injection, Solution · Eugia US LLC
- 55150-232 Fondaparinux Sodium 7.5 mg/.6mL · Injection, Solution · Eugia US LLC
- 55150-233 Fondaparinux Sodium 10 mg/.8mL · Injection, Solution · Eugia US LLC
- 11797-154 Fondaparinux Sodium 2.5 mg/.5mL · Injection, Solution · Italfarmaco S.p.A
- 11797-155 Fondaparinux Sodium 5 mg/.4mL · Injection, Solution · Italfarmaco S.p.A
- 11797-156 Fondaparinux Sodium 7.5 mg/.6mL · Injection, Solution · Italfarmaco S.p.A
- 11797-157 Fondaparinux Sodium 10 mg/.8mL · Injection, Solution · Italfarmaco S.p.A
- 67457-585 Fondaparinux Sodium 10 mg/.8mL · Injection, Solution · Mylan Institutional LLC
- 67457-584 Fondaparinux Sodium 7.5 mg/.6mL · Injection, Solution · Mylan Institutional LLC
- 67457-582 Fondaparinux Sodium 2.5 mg/.5mL · Injection, Solution · Mylan Institutional LLC
- 70710-1517 Fondaparinux Sodium 10 mg/.8mL · Injection, Solution · Zydus Pharmaceuticals (USA) Inc.